ISCHEMIA-CKD EXTEND: Initial invasive management did not improve 8-year survival in stable coronary disease with advanced CKD (2026) — Trial Summary

ISCHEMIA-CKD EXTEND: Initial invasive management did not improve 8-year survival in stable coronary disease with advanced CKD (2026): Long-term extended follow-up of the ISCHEMIA-CKD randomized trial in patients with at least moderate myocardial ischemia and advanced chronic kidney disease. The 777

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.